Adiponectin levels in a large pooled plaque psoriasis study population.
Conclusion: Metabolic syndrome and BMI are key determinants of adiponectin levels in psoriasis patients. Psoriasis severity and anti-psoriatic treatment had no relevant impact on adiponectin levels.
PMID: 31179792 [PubMed - as supplied by publisher]
Source: Journal of Dermatological Treatment - Category: Dermatology Tags: J Dermatolog Treat Source Type: research
More News: Cardiology | Dermatology | Eating Disorders & Weight Management | Enbrel | Heart | Metabolic Syndrome | Obesity | Psoriasis | Skin | Study